Clinical Trial

A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

Name: A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer — clinical trial record (NCT07597629)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, multicenter Phase II clinical study conducted in subjects with advanced breast cancer.

Protocol Amendment History 3 changes

critical Recruitment opened 2026-06-17

notable Enrollment reduced: 114 -> 36 participants 2026-06-17

minor Trial arms changed: 3 -> 1 2026-06-17

Trial Details

NCT Number	NCT07597629
Lead Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions	Advanced Breast Cancer
Enrollment	36 participants
Start Date	2026-05-25
Primary Completion	2027-11-30 (estimated)
Study Completion	2029-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-16